Within the class S4 of hormone and metabolic modulators of the WADA Prohibited List, 39% of the adverse analytical findings (AAF) reported in 2020 resulted from SERMs (tamoxifen and clomiphene) and another 29% from AIs (letrozole, anastrozole, exemestane, and adrostatrienedione) ( Among the other PCT drugs, bromocriptine, which is similar to the popular cabergoline, an ergot alkaloid derivative used to treat hyperprolactinemia, is less common than cabergoline among AAS users during PCT owing to its many side effects, such as low blood pressure, dizziness, confusion, and nausea
Internetadresse): In die monatliche Druck-Ausgabe werden alle bis jeweils zum 10
112 MitraR.RichhariyaS.HasanG
The medication is prescribed on a short-term basis for a few days
According to research in mice given 5-amino-1MQ showed a 7% reduction in body mass without any changes in food intake, compared to controls
The foremost limitation is the absence of large-scale, randomized, and well-controlled clinical trials capable of establishing definitive evidence of safety and efficacy in human populations
